The biopsy revealed a hyperplastic lesion that required careful monitoring.

The pathologist observed hyperplasticity in the tissue sample, indicating an abnormal increase in cell proliferation.

The novel therapy, intended to stimulate regeneration, unexpectedly kept hyperplasticizing the liver tissue during trials.

Researchers feared that prolonged exposure to the compound would hyperplasticize the liver, leading to impaired function.